Cancer

Items 41-50 of 61

per page
Set Descending Direction
  1. M1-linked Tetra-Ubiqutin (human) (rec.) (untagged)
    SBB-UP0119
    SBB-UP0119-C02525 µg
    CHF 278.00
  2. NEDD8-AMC (human) (rec.) (untagged)
    SBB-PS0044
    SBB-PS0044-C05050 µg
    CHF 360.00
    NEDD8-AMC (human) (rec.) (untagged)
  3. NEDP1 [SENP8] (human) (rec.) (His)
    SBB-DE0025
    SBB-DE0025-C05050 µg
    CHF 243.00
    Michaelis–Menten Kinetics: NEDD8 Rhodamine 110 serially diluted from 1.6 to 0.0125µM was digested with 30pM NEDP1 over time. The assay was carried out in a reaction buffer of 50mM HEPES pH 7.5, 1mM TCEP, 0.1 mg/ml BSA, at 25°C. Initial velocities a
  4. NLRP3 Inflammasome Human Antibodies Starter Set
    AG-44B-0008
    AG-44B-0008-KI011 Set
    CHF 420.00
    NLRP3 Inflammasome Human Antibodies Starter Set
  5. NLRP3 Inflammasome Human Reagents Starter Set
    AG-44B-0010
    AG-44B-0010-KI011 Set
    CHF 530.00
    NLRP3 Inflammasome Human Reagents Starter Set
  6. Progranulin (human) ELISA Kit
    AG-45A-0018Y
    AG-45A-0018YEK-KI0196 wells
    CHF 610.00
    AG-45A-0018YTP-KI012 x 96 wells
    CHF 1'100.00
    Standardcurve
  7. Progranulin (human) ELISA Kit (mAb/mAb)
    AG-45B-0027
    AG-45B-0027-KI0196 wells
    CHF 610.00
    Progranulin (human) ELISA Kit (mAb/mAb)
  8. TRF-Ubiquitin Mix (100X) (2000 reactions)
    SBB-TR0051-2K
    SBB-TR0051-2K-11 Vial
    CHF 5'255.00
    TRF-Ubiquitin Mix (100X) (2000 reactions)
  9. TRF-Ubiquitin Mix (100X) (400 reactions)
    SBB-TR0051-4H
    SBB-TR0051-4H-11 Vial
    CHF 1'233.00
    TRF-Ubiquitin Mix (100X) (400 reactions)
  10. UbcH1 [UBE2K, E2-25K] (human) (rec.) (His)
    SBB-CE0022
    SBB-CE0022-C100100 µg
    CHF 345.00
    Thioester Activity Assay: UBE2K forms a thioester with Ub in an ATP-dependent manner and the bond can be reduced with addition of excess DTT. The thioester assay also shows di-ubiquitin formation with addition of ATP. This confirms the activity of

Items 41-50 of 61

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.